Eco-Friendly ingenuities are motivating huge growth in the industry of plant-based plastic packaging market. The industry is chiefly driven by eco-friendly characteristics of these plastic. North America is foretold to be the utmost reve…
BMI View: The Irish government's four-year agreement with the pharmaceutical industry with regard to
drug pricing reflects the government's continued focus on cost control measures targeting pharmaceutical
expenditure. The agreed price-reduction mechanism for existing medicines will, however, allow for the
prioritisation of funding toward ensuring access to new, innovative medicines. While the pharmaceutical
market will continue to decline in value terms, Ireland's robust long-term economic outlook will continue to
support healthcare expenditure expansion. Rising demand for healthcare will be reflected in rising private
health insurance uptake.
Headline Expenditure Projections
? Pharmaceuticals: EUR2.32bn (USD2.53bn) in 2015 to EUR2.27bn (USD2.50bn) in 2016;-2.0% in local
currency terms and -1.0% in US dollar terms. Forecast in line in local currency terms and revised
upwards in US dollar terms from last quarter.
? Healthcare: EUR15.08bn (USD16.42bn) in 2015 to EUR15.48bn (USD17.03bn) in 2016; +2.7% in local
currency terms and 3.7% in US dollar terms. Forecast revised upwards from last quarter.